PlasFree is happy to announce initiating its first clinical study examining its Medical Device CLearPlasma in Upper Gastrointestinal bleeding patients (https://clinicaltrials.gov/ct2/show/NCT04174989?term=clearplasma&draw=2&rank=1).
PlasFree has received funding from the European Union’s Horizon 2020 research and innovation program SME Instrument Phase 1 grant. EU project 882231 - ClearPlasma.
PlasFree has successfully passed Stage 2 assessment confirming its management system by BSI (notified body).
PlasFree has received Seal of Excellence from the European Commission
PlasFree has successfully pass Stage1 assessment confirm the management system is and ready to proceed to Stage 2 for the CE mark assessment done by BSI ( notified body)
Plasfree is now an ISO 13854 certified medical device company
PlasFree has successfully completed pre-clinical trial in pigs liver laceration model